PrEP

HIV+Hep Praises DC, Massachusetts, and Delaware for Protecting PrEP Access

Sep 2, 2026

DC, Massachusetts, and Delaware have joined a growing number of states and jurisdictions acting to guarantee insurance coverage of highly effective HIV prevention medications known as PrEP without cost-sharing or prior authorization. These laws not only enshrine the coverage requirements into state law, but clarify that the full range of PrEP options, including newer long-acting injectables, must be covered. We thank Governor Meyer, Governor Healey, Mayor Bowser, and the lawmakers who championed these protections that will reduce access barriers, and we urge other states to follow their lead.

Mississippi insurer adds PrEP coverage after complaint, but gaps remain

Jun 15, 2026

We are pleased that Blue Cross Blue Shield of Mississippi has taken steps to comply with federal preventive coverage requirements by adding these two PrEP drugs. The people of Mississippi deserve the same benefits of innovative HIV prevention tools that other people across the country have access to. But by excluding other long-acting medications, which are recommended in national HIV treatment and prevention guidelines, Mississippians are still not able to access these highly effective drugs that improve patient adherence.

House Republicans Propose $1 Billion in Cuts to Domestic HIV Programs

Jun 4, 2026

We can’t imagine a country that is unable to conduct basic surveillance of a serious infectious disease, educate and test people, and link them to appropriate treatment or prevention, including PrEP. That is what would happen if the House Republican bill were to pass. Sadly, these proposals will just continue the instability in our nation’s HIV prevention programs, which are primarily conducted at the state and local levels. We urge Congress to reject them, as they did last year.

New CDC HIV surveillance report demonstrates national response must be accelerated

May 19, 2026

This data demonstrates that we are not making significant progress in reducing HIV in the United States and efforts to end HIV, unfortunately, remain stalled. Without a jumpstart of resources and a renewed national commitment and leadership by public officials across the country, we are destined to continue to fall short in meeting our goals.

HIV+Hep asks insurance regulators to investigate concerns Highmark may be diverting copay assistance

May 7, 2026

The HIV+Hepatitis Policy Institute is asking insurance regulators in West Virginia, Pennsylvania, and Delaware to investigate Highmark Blue Cross Blue Shield for what we believe is an effort to profit by diverting copay assistance from drug manufacturers meant to assist patients and splitting the funds between itself a third-party vendor.

House Republicans Propose $1 Billion in Cuts to Domestic HIV Programs

New CDC HIV surveillance report demonstrates national response must be accelerated

Search

Recent Press Releases

Pin It on Pinterest

PrEP

HIV+Hep Praises DC, Massachusetts, and Delaware for Protecting PrEP Access

Mississippi insurer adds PrEP coverage after complaint, but gaps remain

House Republicans Propose $1 Billion in Cuts to Domestic HIV Programs

New CDC HIV surveillance report demonstrates national response must be accelerated

HIV+Hep asks insurance regulators to investigate concerns Highmark may be diverting copay assistance

Search

Press Release Tags

Recent Press Releases

Pin It on Pinterest